F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Warm Fund

HongShan

www.hongshan.com · Hong Kong

“Back transformative entrepreneurs building category-defining companies across technology, healthcare, and consumer sectors, from seed to buyout. Partner with founders throughout the full company lifecycle with capital, operational support, and the network built over 20 years of China and global investing.”

$500K – $2000M
Check Size
Leads
Lead Tendency
$61B
AUM
~1 Month
Timeline
01Investment Thesis

Back transformative entrepreneurs building category-defining companies across technology, healthcare, and consumer sectors, from seed to buyout. Partner with founders throughout the full company lifecycle with capital, operational support, and the network built over 20 years of China and global investing.

Exclusion Criteria

Avoids commoditised low-margin models without clear differentiation, businesses in politically sensitive industries without strong mitigation, and companies targeting small addressable markets.

02Investment Team
NS
Neil Shen
Founding and Managing Partner
MW
Ming Wu
Investment Partner
RZ
Reggie Zhang
Partner
CM
Chris Miao
Partner, Head of Human Capital
YY
Yang Yunxia
Partner, Healthcare
G
Gongyuan
Partner, AI & Technology
03F4 Research Brief

HongShan Research

Overview

HongShan (HSG; 红杉中国), formerly Sequoia Capital China, is one of the world's largest and most successful venture capital and private equity firms. Founded in 2005 by Neil Shen and Zhang Fan as the Chinese arm of Sequoia Capital, the firm became fully independent in 2024 following Sequoia's global restructuring in June 2023. The rebranding to HongShan — a romanisation of its Chinese name meaning "redwood" — reflects its evolution into a fully independent Chinese investment institution.

Investment Thesis

HongShan backs transformative entrepreneurs building category-defining companies across technology, healthcare, and consumer sectors. The firm operates a fully integrated platform spanning seed, venture, growth, buyout, infrastructure, and public equities — one of the few firms globally to cover the entire company lifecycle from inception to IPO and beyond.

Historically, approximately 90% of the firm's returns have come from the consumer, consumer technology, and healthcare sectors. More recently, HongShan has significantly expanded into AI/ML infrastructure, robotics, semiconductors, and deep tech, while also executing major buyout transactions in global consumer brands.

Stage Focus

HongShan invests across the full spectrum:

  • Seed (pre-seed and seed-stage startups)
  • Venture (Series A through Series C)
  • Growth equity (late-stage private companies)
  • Private equity / buyout (controlling stakes in established businesses)
  • Infrastructure investing
  • Public equities (through a dedicated team)

The firm launched a dedicated seed programme (HongShan Seed) to back the earliest-stage founders, and runs YUE, an accelerator programme for pre-seed and seed companies.

Check Size

Given the breadth of the platform, check sizes range dramatically:

  • Seed: $500K–$5M
  • Venture: $10M–$100M
  • Growth: $100M–$500M
  • Buyout / PE: $500M–$2B+

The firm manages USD 61 billion in assets as of April 30, 2026.

Geographic Focus

HongShan is primarily focused on China, but is actively expanding globally:

  • China (primary): Beijing, Shanghai, Shenzhen, and broader Chinese market
  • Greater China: Hong Kong
  • Southeast Asia: Singapore (office opened 2023)
  • Europe: London (office opened October 2024)
  • Japan: Tokyo (office opened February 2025)

The firm is backing Chinese founders going global ("出海") and investing directly in global companies across the US, Europe, and Asia.

Recent Activity

HongShan has been very active globally:

  • July 2024: Raised 18 billion RMB (~$2.5B) for a new RMB-denominated fund — the first major fund raised as an independent entity after the Sequoia split
  • January 2025: Acquired a majority stake in Marshall Group (audio equipment, UK/Sweden) for $1.1B — its largest European investment to date
  • February 2025: Opened Tokyo office, hired ex-Bain Capital dealmaker to lead Japan strategy
  • May 2026: Raised a $3B continuation fund to transfer existing investments
  • December 2025: Acquired majority stake in Golden Goose (Italian luxury fashion) for €2.5B
  • September 2025: Shortlisted to bid for controlling stake in Starbucks China operations
  • October 2025: Bayer AG selling Avelox antibiotics business to HSG
  • Portfolio IPOs: Pony.ai (autonomous driving) and Horizon Robotics (AI chip) both went public

Portfolio Highlights

HongShan has backed over 1,700 companies, with 180+ IPOs and 140+ unicorns:

Iconic China Portfolio:

  • Alibaba (e-commerce; early backer)
  • ByteDance / TikTok (reported $500B valuation in 2025)
  • JD.com (e-commerce)
  • Meituan (food delivery and local services)
  • Pinduoduo (social e-commerce)
  • SHEIN (fast fashion, global)
  • Xiaohongshu / RedNote (social content platform)
  • Ant Group (fintech)
  • Pop Mart (collectibles/IP)

Global Portfolio:

  • Canva (design platform, Australia)
  • Airwallex (global fintech payments, Australia/China)
  • Lalamove (logistics, Hong Kong)
  • Klook (travel activities, Hong Kong)
  • Toss / Viva Republica (Korean fintech super-app)
  • Eight Sleep (sleep tech, US)
  • Monzo (digital bank, UK)
  • PatSnap (R&D intelligence, UK/Singapore)
  • EcoFlow (portable power, China/global)
  • xTool (laser engraving tools, China/global)

Deep Tech / Hardware:

  • Agile Robots (robotics, Germany/China)
  • RIVR / Swiss-Mile (wheeled quadruped robots; acquired by Amazon)
  • Pony.ai (autonomous driving)
  • Horizon Robotics / 地平线 (AI chips for automotive)

Consumer / Lifestyle Acquisitions:

  • AMI Paris (luxury fashion; majority stake acquired 2021)
  • Marshall Group (audio equipment; majority stake acquired Jan 2025, $1.1B)
  • Golden Goose (Italian luxury footwear; majority stake acquired Dec 2025, €2.5B)

Team

  • Neil Shen (沈南鹏) — Founding and Managing Partner; co-founded the firm in 2005; four-time topper of the Forbes Midas List; Forbes China #1 venture investor
  • 公元 (Gongyuan) — Partner, AI & Technology focus; active in AI agent investments and hosts the "The Prompt" podcast series
  • Ming Wu (吴茗) — Investment Partner; focus on gaming and AI-native products
  • Reggie Zhang (张涵) — Partner; key venture investor
  • Chris Miao (缪海源) — Partner and Head of Human Capital
  • Yang Yunxia (杨云霞) — Partner, Healthcare; leads biopharma and medical devices
  • Li Annie (李安妮) — Partner, Healthcare M&A
  • Pu Xiaoyan (浦晓燕) — Partner
  • He Tiantian (何田田) — Partner
  • Su Kai (苏凯) — Partner
  • Sun Qian (孙谦) — Partner
  • Wang Kai (王恺) — Partner
  • Ye Xiaohui (叶小慧) — Partner and CFO
  • Zhang Lianqing (张联庆) — Partner and General Counsel
  • Jia Qin (贾沁) — Partner, M&A
  • Liu Xing (刘星) — Partner
  • Xu Qing (徐青) — Partner, Infrastructure Investing

Decision Process

Given the scale of the firm (300+ employees), HongShan operates through an investment committee model. Deals are driven by sector-specific partners and then approved by the broader partnership. The firm runs both fast-moving early-stage processes (seed/Series A) and longer due diligence for large growth and buyout transactions.

Founder Preferences

HongShan looks for founders with:

  • Deep domain expertise and technical differentiation
  • Large and defensible market opportunities
  • Global ambitions and cross-border execution capabilities
  • Strong product instincts and team-building capacity
  • For seed: conviction and velocity; for growth: proven metrics and unit economics

The firm runs multiple programmes — YUE accelerator, HongShan Scholars (红杉学者), and campus recruiting partnerships — to find and develop talent.

Anti-Thesis

HongShan avoids businesses with:

  • Purely commoditised, low-margin models without clear differentiation
  • Regulatory-heavy models in politically sensitive industries
  • Companies targeting only small addressable markets

Geopolitical Context

Since the Sequoia split in 2023, HongShan operates as a fully independent Chinese firm. It continues to draw investment from major US institutional LPs (CalPERS, CPP, University of California Regents) despite scrutiny from the US House Select Committee on China competition. The firm has made clear it will continue global expansion while remaining based in Hong Kong.

04Selected Portfolio
Climate & Sustainability
EcoFlow
E-commerce & Marketplaces
Alibaba·Meituan·PDD Holdings·Golden Goose·AMI Paris·Amer Sports
Enterprise Software
Canva·PatSnap
Fintech & Payments
Airwallex·Ant Group·Monzo
Healthcare & Digital Health
Eight Sleep
Logistics & Supply Chain
Lalamove
Media & Entertainment
ByteDance·Pop Mart
Mobility & Transportation
Pony.ai
Robotics & Automation
Agile Robots
Semiconductors & Hardware
Marshall Group
Travel & Hospitality
Klook
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (10) →
HongShan introduced xbench, an evergreen benchmark framework for evaluating AI agents, demonstrating deep AI research capabilities.
ESSAY·hsgcap.com
Added recently
Portfolio company RIVR (formerly Swiss-Mile), maker of wheeled quadruped robots, was acquired by Amazon.
EXIT·therobotreport.com+1
Added recently
Portfolio company Horizon Robotics (AI chips for automotive) went public.
EXIT·hongshan.com
Added recently
Portfolio company Pony.ai (autonomous driving) successfully went public.
EXIT·hongshan.com
Added recently
HongShan raised a $3 billion continuation fund to transfer existing investments.
NEW FUND·caproasia.com
MAY 2026
06Frequent co-investors
IG
ICONIQ Growth
Both backed 3 of the same companies
Canva, Alibaba, Monzo
TP
TeleSoft Partners
Both backed 3 of the same companies
PDD Holdings, ByteDance, Meituan
AV
AirTree Ventures
Both backed 2 of the same companies
Airwallex, Canva
AW
Alpha Wave Global
Both backed 2 of the same companies
Alibaba, Monzo
B
Blackbird
Both backed 2 of the same companies
Airwallex, Canva
Find the investors for your round→
07Similar Firms
IC
IDG Capital
$1M – $100M · Seed · Series A
→
BC
BAI Capital
Series A · Series B
→
CT
Capital Today
$5M – $300M · Series A · Growth
→
XL
XRC Labs
$200K – $3M · Pre-Seed · Seed
→
DC
Decent Capital
$100K – $10M · Pre-Seed · Seed
→
Quick Reference
Check Size
$500K – $2000M
Stages
Seed · Series A · Series B · Series C · Growth
AUM
$61B
Decision
Investment Committee · ~1 Month
Warm Intro
Preferred
Involvement
Board Seat
Location
Hong Kong
Sector Focus
Fintech & PaymentsConsumer Apps & SocialE-Commerce & MarketplacesBiotech & Life SciencesSemiconductors & HardwareLogistics & Supply ChainRobotics & AutomationEnterprise SoftwareMedia & EntertainmentHealthcare & Digital Health
Models
Consumer TechEnterprise SaaSDeep TechConsumer Brands
Technology
Ai MlHardware
See all Fintech & Payments investors →See all Consumer Apps & Social investors →See all E-commerce & Marketplaces investors →
Visit www.hongshan.com ↗

See how HongShan matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Fintech & PaymentsConsumer Apps & SocialE-Commerce & MarketplacesBiotech & Life SciencesSemiconductors & HardwareLogistics & Supply ChainRobotics & AutomationEnterprise SoftwareMedia & EntertainmentHealthcare & Digital Health

See how HongShan matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched July 12, 2026F4 Research Engine